Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade–Resistant Advanced NSCLC

Marcelo V. Negrao, Vassiliki A. Papadimitrakopoulou, Andrew C. Price, Alda L. Tam, Muhammad Furqan, Sandeep T. Laroia, Erminia Massarelli, Jose Pacheco, John V. Heymach, Anne S. Tsao, Gary V. Walker, Lalit Vora, David Mauro, Heather Kelley, James E. Wooldridge, Arthur M. Krieg, Jiaxin Niu

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade–Resistant Advanced NSCLC'. Together they form a unique fingerprint.

Medicine & Life Sciences